Works matching Reverse transcriptase inhibitors

Results: 4357

Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.

Published in:

HIV Medicine, 2018, v. 19, n. 1, p. 18, doi. 10.1111/hiv.12534

By:

Orkin, C.;
Llibre, J. M.;
Gallien, S.;
Antinori, A.;
Behrens, G. M. N.;
Carr, A.

Publication type:

Article

Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9059, doi. 10.3390/ijms25169059

By:

Bush, Keegan;
Wairkar, Yogesh;
Tang, Shao-Jun

Publication type:

Article

High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana; A 2017 study.

Published in:

Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.973771

By:

Parbie, Prince Kofi;
Abana, Christopher Zaab-Yen;
Kushitor, Dennis;
Asigbee, Theodore Worlanyo;
Ntim, Nana Afia Asante;
Addo-Tetebo, Gifty;
Ansong, Maclean Richard Darko;
Ofori, Sampson Badu;
Taketoshi Mizutani;
Runtuwene, Lucky Ronald;
Masako Nishizawa;
Koichi Ishikawa;
Hiroshi Kiyono;
Ampofo, William Kwabena;
Tetsuro Matano;
Bonney, Evelyn Yayra;
Tadashi Kikuchi

Publication type:

Article

Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present).

Published in:

Arabian Journal of Chemistry, 2022, v. 15, n. 12, p. N.PAG, doi. 10.1016/j.arabjc.2022.104378

By:

Deng, Cui;
Yan, Heng;
Wang, Jun;
Liu, Kai;
Liu, Bao-shan;
Shi, Yu-min

Publication type:

Article

Challenges and approaches in the discovery of human immunodeficiency virus type‐1 non‐nucleoside reverse transcriptase inhibitors.

Published in:

Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1235, doi. 10.1002/med.21544

By:

Battini, Leandro;
Bollini, Mariela

Publication type:

Article

Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.

Published in:

HIV Medicine, 2013, v. 14, n. 9, p. 571, doi. 10.1111/hiv.12044

By:

Santoro, MM;
Sabin, C;
Forbici, F;
Bansi, L;
Dunn, D;
Fearnhill, E;
Boumis, E;
Nicastri, E;
Antinori, A;
Palamara, G;
Callegaro, A;
Francisci, D;
Zoncada, A;
Maggiolo, F;
Zazzi, M;
Perno, CF;
Ceccherini‐Silberstein, F;
Mussini, C

Publication type:

Article

Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.

Published in:

HIV Medicine, 2013, v. 14, n. 3, p. 176, doi. 10.1111/j.1468-1293.2012.01037.x

By:

Pingen, M;
Ende, ME;
Wensing, AM;
Barzouhi, A;
Simen, BB;
Schutten, M;
Boucher, CAB

Publication type:

Article

Antiangiogenic VEGF165b Expression in Human Breast MCF-7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors.

Published in:

International Journal of Morphology, 2017, v. 35, n. 1, p. 148, doi. 10.4067/S0717-95022017000100024

By:

Gbenga Anthony, Adefolaju;
Kathrine Elizabeth, Scholtz;
Margot Jill, Hosie

Publication type:

Article

Reverse-transcriptase inhibitors for chronic hepatitis B.

Published in:

Geneesmiddelenbulletin, 2022, n. 11, p. 1, doi. 10.35351/gebu.2022.7.14

By:

Stolk, Leo M. L.

Publication type:

Article

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.

Published in:

PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0162775

By:

Rutherford, George W.;
Horvath, Hacsi

Publication type:

Article

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries

Published in:

Viruses (1999-4915), 2024, v. 16, n. 12, p. 1853, doi. 10.3390/v16121853

By:

Gouissi Anguechia, Davy-Hyacinthe;
Bouba, Yagai;
Semengue, Ezechiel Ngoufack Jagni;
Ka'e, Aude Christelle;
Takou, Désiré;
Ambe Chenwi, Collins;
Beloumou, Grace;
Nka, Alex Durand;
Basseck Wome, Ulrich Roland;
Santoro, Maria Mercedes;
Ceccherini-Silberstein, Francesca;
Chatté, Adawaye;
Montesano, Carla;
Cappelli, Giulia;
Colizzi, Vittorio;
Ndjolo, Alexis;
Mbanya, Dora;
Ndembi, Nicaise;
Perno, Carlo-Federico;
Fokam, Joseph

Publication type:

Article

Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.

Published in:

Journal of the International AIDS Society, 2013, v. 16, n. 1, p. 1, doi. 10.7448/IAS.16.1.18567

By:

Usach, Iris;
Melis, Virginia;
Peris, José‐Esteban

Publication type:

Article

HIV drug nucleoside reverse transcriptase inhibitors as promising anti-inflammation therapeutics by targeting P2X7-dependent large pore formation: one stone for two birds?

Published in:

2015

By:

Lin-Hua Jiang;
Mizanur, Rahman M.

Publication type:

Opinion

Evaluation of nucleoside reverse transcriptase inhibitor dosing during continuous veno-venous hemofiltration.

Published in:

2017

By:

McLaughlin, Milena;
Masic, Inela;
Gerzenshtein, Lana;
McLaughlin, Milena M

Publication type:

journal article

Nucleoside analog reverse transcriptase inhibitor induced lactic acidosis treated with continuous renal replacement in the medical intensive care unit.

Published in:

2012

By:

Orija, Abiodun Ayo;
Jenks, Christopher Loren

Publication type:

Case Study

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.

Published in:

HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386

By:

Girard, PM;
Antinori, A;
Arribas, JR;
Ripamonti, D;
Bicer, C;
Netzle‐Sveine, B;
Hadacek, B;
Moecklinghoff, C

Publication type:

Article

Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors.

Published in:

HIV Medicine, 2014, v. 15, n. 8, p. 488, doi. 10.1111/hiv.12145

By:

Simpson, KN;
Chen, S‐Y;
Wu, AW;
Boulanger, L;
Chambers, R;
Nedrow, K;
Tawadrous, M;
Pashos, CL;
Haider, S

Publication type:

Article

No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.

Published in:

HIV Medicine, 2012, v. 13, n. 7, p. 448, doi. 10.1111/j.1468-1293.2012.00995.x

By:

Welzen, BJ;
Mudrikova, T;
Arends, JE;
Hoepelman, AIM

Publication type:

Article

Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors.

Published in:

Pharmaceutical Chemistry Journal, 2012, v. 46, n. 7, p. 397, doi. 10.1007/s11094-012-0808-y

By:

Valuev-Elliston, V.;
Ivanov, A.;
Orlinson, B.;
Gerasimov, E.;
Brunilina, L.;
Kochetkov, S.;
Novakov, I.;
Navrotskii, M.

Publication type:

Article

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

Published in:

2020

By:

Milanés-Guisado, Yusnelkis;
Gutiérrez-Valencia, Alicia;
Muñoz-Pichardo, Juan Manuel;
Rivero, Antonio;
Trujillo-Rodriguez, Maria;
Ruiz-Mateos, Ezequiel;
Espinosa, Nuria;
Roca-Oporto, Cristina;
Viciana, Pompeyo;
López-Cortés, Luis F

Publication type:

journal article

Liver Damage During Treatment with Reverse-Transcriptase Inhibitors in HIV Patients.

Published in:

Current Health Sciences Journal, 2024, v. 50, n. 2, p. 181, doi. 10.12865/CHSJ.50.02.03

By:

LUNGU, GIORGIANA NICOLETA;
DIACONESCU, GHEORGHE IULIAN;
DUMITRESCU, FLORENTINA;
DOCEA, ANCA OANA;
MITRUT, RADU;
GIUBELAN, LUCIAN;
ZLATIAN, OVIDIU;
MITRUT, PAUL

Publication type:

Article

METHODS FOR MONITORING MITOCHONDRIAL TOXICITY OF NUCLEOSIDE-ANALOGUE REVERSE-TRANSCRIPTASE INHIBITORS IN HIV PATIENTS DURING ANTIRETROVIRAL THERAPY.

Published in:

Therapeutics, Pharmacology & Clinical Toxicology, 2011, v. 15, n. 4, p. 289

By:

Tilişcan, C.;
Aramă, Victoria;
Mihăilescu, Raluca;
Streinu-Cercel, A.;
Ion, Daniela;
Aramă, Ş. S.

Publication type:

Article

Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK‐8507, an Investigational, Oral, Once‐Weekly Nonnucleoside Reverse Transcriptase Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 2, p. 199, doi. 10.1002/jcph.1957

By:

Gillespie, Gillian;
Jackson Rudd, Deanne;
Zhang, Saijuan;
Schaeffer, Andrea;
Tomek, Charles;
Larson, Patrick;
Stoch, S. Aubrey;
Iwamoto, Marian

Publication type:

Article

Discovery of a semi-synthesized cyclolignan as a potent HIV-1 non-nucleoside reverse transcriptase inhibitor.

Published in:

Journal of Asian Natural Products Research, 2019, v. 21, n. 1, p. 76, doi. 10.1080/10286020.2017.1417266

By:

Guo, Jia-Mei;
Ba, Ming-Yu;
Yang, Ying;
Yao, Chun-Suo;
Yu, Miao;
Shi, Jian-Gong;
Guo, Ying

Publication type:

Article

Determination of the Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine, and Didanosine in Human Urine by Micellar Electrokinetic Chromatography Using the Ionic Liquid-Based Cationic Surfactant 1-Tetradecyl-3-Methylimidazolium Bromide.

Published in:

Analytical Letters, 2021, v. 54, n. 18, p. 2929, doi. 10.1080/00032719.2021.1904970

By:

Xu, Lei;
Lu, Jing;
Meng, Weiqi;
Cui, Fengjuan

Publication type:

Article

DEVELOPMENT OF BENZIMIDAZOLE DERIVATIVES AS NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHIBITORS (REVIEW).

Published in:

Journal of Chemical Technology & Metallurgy, 2022, v. 57, n. 1, p. 3

By:

Anichina, Kameliya;
Mavrova, Anelia

Publication type:

Article

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine.

Published in:

Viruses (1999-4915), 2024, v. 16, n. 11, p. 1715, doi. 10.3390/v16111715

By:

Nagarajan, Pavithra;
Zhou, Jinru;
Di Teodoro, Giulia;
Incardona, Francesca;
Seguin-Devaux, Carole;
Kaiser, Rolf;
Abecasis, Ana B.;
Gomes, Perpetua;
Tao, Kaiming;
Zazzi, Maurizio;
Shafer, Robert W.

Publication type:

Article

Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.

Published in:

Viruses (1999-4915), 2024, v. 16, n. 4, p. 582, doi. 10.3390/v16040582

By:

Vos, Wilhelm A. J. W.;
Vadaq, Nadira;
Matzaraki, Vasiliki;
Otten, Twan;
Groenendijk, Albert L.;
Blaauw, Marc J. T.;
van Eekeren, Louise E.;
Brinkman, Kees;
de Mast, Quirijn;
Riksen, Niels P.;
Stalenhoef, Anton F. H.;
van Lunzen, Jan;
van der Ven, Andre J. A. M.;
Blok, Willem L.;
Stalenhoef, Janneke E.

Publication type:

Article

Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors.

Published in:

Viruses (1999-4915), 2024, v. 16, n. 4, p. 491, doi. 10.3390/v16040491

By:

Costa-Tuna, Andreia;
Chaves, Otávio A.;
Almeida, Zaida L.;
Cunha, Rita S.;
Pina, João;
Serpa, Carlos

Publication type:

Article

The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors.

Published in:

Viruses (1999-4915), 2023, v. 15, n. 11, p. 2234, doi. 10.3390/v15112234

By:

Fernandes, Lívia da Rocha;
Lopes, Juliana Romano;
Bonjorno, Andressa Francielli;
Prates, João Lucas Bruno;
Scarim, Cauê Benito;
Dos Santos, Jean Leandro

Publication type:

Article

Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions.

Published in:

Viruses (1999-4915), 2016, v. 8, n. 10, p. 263, doi. 10.3390/v8100263

By:

Ming-Tain Lai;
Vandna Munshi;
Meiqing Lu;
MeiZhen Feng;
Hrin-Solt, Renee;
McKenna, Philip M.;
Hazuda, Daria J.;
Miller, Michael D.

Publication type:

Article

Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence.

Published in:

Cardiovascular Toxicology, 2019, v. 19, n. 6, p. 500, doi. 10.1007/s12012-019-09520-1

By:

Chen, Yi-Fan;
Hebert, Valeria Y.;
Stadler, Krisztian;
Xue, Stephen Y.;
Slaybaugh, Kate;
Luttrell-Williams, Elliot;
Glover, Mitzi C.;
Krzywanski, David M.;
Dugas, Tammy R.

Publication type:

Article

Nucleoside Reverse Transcriptase Inhibitors Induce a Mitophagy-Associated Endothelial Cytotoxicity That Is Reversed by Coenzyme Q10 Cotreatment.

Published in:

Toxicological Sciences, 2013, v. 134, n. 2, p. 323, doi. 10.1093/toxsci/kft105

By:

Xue, Stephen Y.;
Hebert, Valeria Y.;
Hayes, Danicia M.;
Robinson, Corie N.;
Glover, Mitzi;
Dugas, Tammy R.

Publication type:

Article

LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S996, doi. 10.1093/ofid/ofz415.2492

By:

Rebeiro, Peter F;
Jenkins, Cathy;
Bian, Aihua;
Lake, Jordan;
Bourgi, Kassem;
Horberg, Michael A;
Moore, Richard;
Altoff, Keri;
Klein, Marina;
Eron, Joseph J;
Gill, M John;
Kitahata, Mari;
Napravnik, Sonia;
Silverberg, Michael;
Mayor, Angel M;
Willig, Amanda;
Floris-Moore, Michelle;
Sterling, Timothy;
Koethe, John R

Publication type:

Article

Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.

Published in:

Pharmaceuticals (14248247), 2020, v. 13, n. 6, p. 122, doi. 10.3390/ph13060122

By:

Himmel, Daniel M.;
Arnold, Eddy

Publication type:

Article

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment.

Published in:

HIV Medicine, 2020, v. 21, n. 9, p. 599, doi. 10.1111/hiv.12888

By:

Mocroft, A;
Neesgard, B;
Zangerle, R;
Rieger, A;
Castagna, A;
Spagnuolo, V;
Antinori, A;
Lampe, FC;
Youle, M;
Vehreschild, JJ;
Mussini, C;
Borghi, V;
Begovac, J;
Duvivier, C;
Gunthard, HF;
Rauch, A;
Tiraboschi, J;
Chkhartishvili, N;
Bolokadze, N;
Wit, F

Publication type:

Article

Comparison of 48‐week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor‐sparing regimens: a systematic review and network meta‐analysis.

Published in:

HIV Medicine, 2018, v. 19, n. 8, p. 559, doi. 10.1111/hiv.12643

By:

Gallien, S.;
Massetti, M.;
Flandre, P.;
Leleu, H.;
Descamps, D.;
Lazaro, E.

Publication type:

Article

Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.

Published in:

2021

By:

Gange, William S.;
Qiao, James B.;
Park, Paul J.;
McDonnell, James F.;
Tan, Zhiqun;
Perlman, Jay I.;
Bu, Ping

Publication type:

journal article

No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 126, doi. 10.1093/jac/dkae383

By:

García-Abellán, Javier;
García, José A;
Padilla, Sergio;
Fernández-González, Marta;
Agulló, Vanesa;
Mascarell, Paula;
Botella, Ángela;
Gutiérrez, Félix;
Masiá, Mar

Publication type:

Article

Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 408, doi. 10.3390/ph17040408

By:

Chow, Tiffany W.;
Raupp, Mark;
Reynolds, Matthew W.;
Li, Siying;
Kaeser, Gwendolyn E.;
Chun, Jerold

Publication type:

Article

Molecular Modeling, Synthesis, and Anti- HIV Activity of Novel Isoindolinedione Analogues as Potent Non-nucleoside Reverse Transcriptase Inhibitors.

Published in:

Chemical Biology & Drug Design, 2016, v. 87, n. 2, p. 200, doi. 10.1111/cbdd.12620

By:

Kumari, Garima;
Singh, Ramendra K.

Publication type:

Article

Synthesis and Biological Evaluation of 2-Thioxopyrimidin-4(1H)-one Derivatives as Potential Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Published in:

International Journal of Molecular Sciences, 2014, v. 15, n. 11, p. 20723, doi. 10.3390/ijms151120723

By:

Khalifa, Nagy M.;
Al-Omar, Mohamed A.

Publication type:

Article

Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors.

Published in:

2018

By:

Lai, Ming-Tain;
Tawa, Paul;
Auger, Anick;
Wang, Deping;
Hua-Poo Su;
Youwei Yan;
Hazuda, Daria J.;
Miller, Michael D.;
Asante-Appiah, Ernest;
Melnyk, Roman A.;
Su, Hua-Poo;
Yan, Youwei

Publication type:

journal article

Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 6, p. 657, doi. 10.1002/jcph.252

By:

Urata, Y.;
Paintsil, E.;
Cheng, Y.‐C.;
Matsuda, T.;
Sevinsky, H.;
Hawthorne, D.;
Bertz, R.;
Hanna, G.J.;
Grasela, D.;
Hwang, C.

Publication type:

Article

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine.

Published in:

Journal of Infectious Diseases, 2013, v. 207, n. suppl_2, p. S70, doi. 10.1093/infdis/jit114

By:

Tang, Michele W.;
Rhee, Soo-Yon;
Bertagnolio, Silvia;
Ford, Nathan;
Holmes, Susan;
Sigaloff, Kim C.;
Hamers, Raph L.;
de Wit, Tobias F. Rinke;
Fleury, Herve J.;
Kanki, Phyllis J.;
Ruxrungtham, Kiat;
Hawkins, Claudia A.;
Wallis, Carole L.;
Stevens, Wendy;
van Zyl, Gert U.;
Manosuthi, Weerawat;
Hosseinipour, Mina C.;
Ngo-Giang-Huong, Nicole;
Belec, Laurent;
Peeters, Martine

Publication type:

Article

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

Published in:

2013

By:

Tang, Michele W;
Rhee, Soo-Yon;
Bertagnolio, Silvia;
Ford, Nathan;
Holmes, Susan;
Sigaloff, Kim C;
Hamers, Raph L;
de Wit, Tobias F Rinke;
Fleury, Herve J;
Kanki, Phyllis J;
Ruxrungtham, Kiat;
Hawkins, Claudia A;
Wallis, Carole L;
Stevens, Wendy;
van Zyl, Gert U;
Manosuthi, Weerawat;
Hosseinipour, Mina C;
Ngo-Giang-Huong, Nicole;
Belec, Laurent;
Peeters, Martine

Publication type:

journal article

Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next‐generation sequencing in HIV‐positive patients.

Published in:

Journal of Medical Virology, 2021, v. 93, n. 6, p. 3627, doi. 10.1002/jmv.26582

By:

Tekin, Duygu;
Gokengin, Deniz;
Onay, Huseyin;
Erensoy, Selda;
Sertoz, Ruchan

Publication type:

Article

Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs).

Published in:

Cardiovascular Toxicology, 2012, v. 12, n. 2, p. 123, doi. 10.1007/s12012-011-9148-5

By:

Liu, Yongmin;
Nguyen, Phuonggiang;
Baris, Tara;
Poirier, Miriam

Publication type:

Article

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 5, p. 1362, doi. 10.1093/jac/dkt532

By:

Markowitz, Martin;
Zolopa, Andrew;
Squires, Kathleen;
Ruane, Peter;
Coakley, Dion;
Kearney, Brian;
Zhong, Lijie;
Wulfsohn, Michael;
Miller, Michael D.;
Lee, William A.

Publication type:

Article

Clinical benefits of novel non‐nucleoside reverse transcriptase inhibitors: A prospective cohort study.

Published in:

Immunity, Inflammation & Disease, 2024, v. 12, n. 4, p. 1, doi. 10.1002/iid3.1217

By:

Ma, Shujing;
Xie, Xiaoxin;
Fu, Yanhua;
Gan, Lin;
Yang, Xiaoyan;
Kong, Linghong;
Li, Jun;
Long, Hai

Publication type:

Article